Musculoskeletal

Focused ultrasound can be utilized to treat several painful bone conditions.

The technology is approved in Europe and the U.S. to relieve the pain in patients with bone metastases. It is also currently approved in Europe to reduce the pain associated with back pain originating from facet arthritis by non-invasively destroying the nerves of the affected facet joint. In addition, focused ultrasound is approved to heat and destroy small benign bone tumors in children and adults (such as osteoid osteoma).

A clinical trial will soon start in the U.S. to assess focused ultrasound for treating sacroilitis, an inflammation of the sacroiliac joint (where the lower spine and pelvis connect).

In addition, groups around the world are evaluating the potential of focused ultrasound to alleviate osteoarthritic pain of the knee. 

Learn more about focused ultrasound for:

clinical stages key
Back Pain Outside Approval icon Clinical Trials icon  
Bone Cancer Clinical Trials icon    
Bone Metastases FDA Approved icon Outside Approval icon Clinical Trials icon
Bone Tumors, Benign Outside Approval icon    
Disc Degeneration Clinical Trials icon    
Muscle Atrophy Early Stage icon    
Osteoarthritis Clinical Trials icon    
Osteoid Osteoma Outside Approval icon Clinical Trials icon  
Plantar Fasciitis Clinical Trials icon    
Sacral Chordomas Clinical Trials icon    
Sacroiliitis Clinical Trials icon    
Soft Tissue Cancer Outside Approval icon Clinical Trials icon  
Soft Tissue Tumors, Benign Outside Approval icon Clinical Trials icon  
Spinal Cord Injury Early Stage icon    

 

 

Clinical Trials icon
     

Share this page

 

In this section

Treatment Sites

Clinical Trials